Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer

NCT01987232 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Extensive-Stage Small-Cell Lung Cancer

Interventions

DRUG: Carfilzomib
DRUG: Carboplatin
DRUG: Etoposide

Sponsor

Amgen